Ticker > Company >

Natural Capsules share price

Natural Capsules Ltd.

NSE: NATCAPSUQ BSE: 524654 SECTOR: Pharmaceuticals & Drugs  31.32 K   64   4

148.86
-1.22 (-0.81%)
NSE: 24 Jul 4:00 PM

Price Summary

Today's High

₹ 154

Today's Low

₹ 145

52 Week High

₹ 296

52 Week Low

₹ 136.36

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

154.98 Cr.

Enterprise Value

210.86 Cr.

No. of Shares

1.04 Cr.

P/E

13.82

P/B

0.87

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  171.47

CASH

2.25 Cr.

DEBT

58.12 Cr.

Promoter Holding

50.92 %

EPS (TTM)

₹  10.77

Sales Growth

3.47%

ROE

6.51 %

ROCE

9.28%

Profit Growth

67.09 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Natural Capsules Ltd.

Veenat Lenalid Erlonat Geftinat Sorafenat Bortenat

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year3.47%
3 Year0.17%
5 Year16.92%

Profit Growth

1 Year67.09%
3 Year-16.41%
5 Year10.25%

ROE%

1 Year6.51%
3 Year5.71%
5 Year10.98%

ROCE %

1 Year9.28%
3 Year8.38%
5 Year13.71%

Debt/Equity

0.3256

Price to Cash Flow

4.29

Interest Cover Ratio

3.419

CFO/PAT (5 Yr. Avg.)

1.43972881448044

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 50.92 0.00
Mar 2026 51.04 0.00
Dec 2025 51.26 0.00
Sep 2025 51.26 0.00
Jun 2025 51.26 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.208233922420068.
  • The company has an efficient Cash Conversion Cycle of 7.3777 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.43972881448044.
  • The company has a high promoter holding of 50.92%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 5.10489612870282.

 Limitations

  • The company has shown a poor profit growth of -16.4080156161295% for the Past 3 years.
  • The company has shown a poor revenue growth of 0.173798034209494% for the Past 3 years.
  • Company has a poor ROE of 5.7078% over the past 3 years.
  • Company has contingent liabilities of 75.2373 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 44.36 44.24 44.58 34.15 50.8
Total Expenditure 39.31 39.11 39.14 32.25 41.95
Operating Profit 5.05 5.13 5.44 1.9 8.86
Other Income 1.55 1.69 1.73 2.11 2.13
Interest 1.53 1.36 1.45 1.45 1.49
Depreciation 1.94 1.99 2.02 2.09 2.06
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.13 3.48 3.7 0.46 7.43
Tax 0.51 0.96 0.89 0.1 1.91
Profit After Tax 2.63 2.52 2.81 0.36 5.52
Adjusted EPS (Rs) 2.54 2.44 2.72 0.35 5.31

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 135.07 172.87 153.81 167.94 173.77
Total Expenditure 110.66 138.17 134.53 148.63 154.3
Operating Profit 24.41 34.7 19.28 19.31 19.47
Other Income 2.14 2.12 4.77 4.41 9.99
Interest 2.08 3.88 5.09 6.09 6.23
Depreciation 5.04 7.2 8.57 8.33 8.16
Exceptional Items 0 0 0 0 0
Profit Before Tax 19.43 25.74 10.39 9.3 15.07
Tax 5.47 6.55 2.59 2.59 3.85
Net Profit 13.76 19.2 7.81 6.71 11.21
Adjusted EPS (Rs.) 19.9 20.7 8.36 6.49 10.8

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 7.01 9.28 9.33 10.34 10.39
Total Reserves 76.04 114.78 122.53 155.98 169.32
Borrowings 14.75 23.01 26.47 19.99 18.98
Other N/C liabilities 2.28 3.18 3.39 6.45 6.72
Current liabilities 43.41 60.15 69.54 77.02 90.6
Total Liabilities 143.49 210.4 231.26 269.78 296.01
Assets
Net Block 62.94 93.22 90.51 88.16 87.76
Capital WIP 1.07 0 2.12 0 1.91
Intangible WIP 0 0 0 0 0
Investments 0.05 20.01 22.74 22.74 22.74
Loans & Advances 21.6 21.52 24.1 60.03 91.27
Other N/C Assets 0.41 1 0.57 0.53 0.88
Current Assets 57.42 74.65 91.23 98.32 91.45
Total Assets 143.49 210.4 231.26 269.78 296.01
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 19.43 25.74 10.39 9.3 15.07
Adjustment 6.33 9.9 11.96 10.93 9.4
Changes in Assets & Liabilities -15.92 -10.09 -14.99 -0.12 15.31
Tax Paid -4.74 -5.46 -1.97 -2.07 -3.62
Operating Cash Flow 5.09 20.1 5.4 18.03 36.16
Investing Cash Flow -30.42 -55.42 -10.84 -34.37 -33.76
Financing Cash Flow 26.51 34.45 7.23 14.81 -2.85
Net Cash Flow 1.18 -0.87 1.79 -1.53 -0.45

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 51.26 51.26 51.26 51.04 50.92
chandra rameshwar laddha 0.01 0.01 0.01 0.01 0.01
indra mundra 3.79 3.79 3.79 3.77 3.76
jyoti mundra 2.97 2.97 2.97 2.95 2.95
jyotsna daga - 0.37 0.37 0.36 0.36
laxminarayan moondra 2.33 2.33 2.33 2.32 2.31
madhav mundra 1.60 1.60 1.60 1.59 1.59
nandi synthetics pvt ltd 8.89 8.89 8.89 8.85 8.83
nidhi sethia 0.18 0.18 0.18 0.18 0.18
radha s mundra 2.32 2.32 2.32 2.30 2.30
satyanarayan mundra 1.79 1.79 1.79 1.78 1.78
sharada mundra 2.56 2.56 2.56 2.55 2.55
shrey mundra 1.60 1.60 1.60 1.59 1.59
sunil laxminaryan mundra 5.82 5.82 5.82 5.80 5.79
sushil kumar mundra 4.92 4.92 4.92 4.90 4.89
tajos investments private... 12.12 12.12 12.12 12.07 12.04
jyotsna daga 0.37 - - - -
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 48.74 48.74 48.74 48.96 49.08
anurag singhi 1.29 1.32 1.42 1.65 1.69
investor education and pr... - - - - 1.31
llp 0.08 0.08 0.08 0.31 0.22
narendra dharmsinh sampat... 1.45 1.45 1.45 1.32 1.32
pcg finvest private limit... - - - 1.60 1.60
sangeetha s 3.16 3.16 3.16 3.15 3.14
tarinika management llp 3.22 3.22 3.22 3.27 2.74
vivog commercial limited 1.44 1.44 1.44 1.44 1.43
investor education and pr... 1.20 1.19 1.32 1.32 -
pcg finvest private ltd 1.61 1.61 1.61 - -

Annual Reports

Title Link
Title Link
Annual Report 2026
Annual Report 2024
Annual Report 2023
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY23
Presentation Q3FY24
Presentation Q3FY23

Company News

 No Latest News available for this company.Report us

Natural Capsules Stock Price Analysis and Quick Research Report. Is Natural Capsules an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Natural Capsules. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Natural Capsules has a PE ratio of 13.8204437842354 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Natural Capsules has ROA of 3.964% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Natural Capsules has a Current ratio of 1.0094.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Natural Capsules has a ROE of 6.5119%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Natural Capsules has a Debt to Equity ratio of 0.3256 which means that the company has low proportion of debt in its capital.

  • Sales growth: Natural Capsules has reported revenue growth of 3.4731% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Natural Capsules for the current financial year is 11.2030840606799%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Natural Capsules is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Natural Capsules is Rs 10.771. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Natural Capsules in Ticker for free. Also, one can get the intrinsic value of Natural Capsules by using Valuation Calculators, which are available with a Finology ONE subscription. 

Natural Capsules FAQs

Q1. What is Natural Capsules share price today?
Ans: The current share price of Natural Capsules is Rs 148.86.

Q2. What is the market capitalisation of Natural Capsules?
Ans: Natural Capsules has a market capitalisation of Rs 154.980438444 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Natural Capsules?
Ans: The PE ratio of Natural Capsules is 13.8204437842354 and the P/B ratio of Natural Capsules is 0.868122985839203, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Natural Capsules share?
Ans: The 52-week high share price of Natural Capsules is Rs 296, and the 52-week low share price of Natural Capsules is Rs 136.36.

Q5. Does Natural Capsules pay dividends?
Ans: Currently, Natural Capsules does not pay dividends. Dividend yield of Natural Capsules is around 0%.

Q6. What are the face value and book value of Natural Capsules shares?
Ans: The face value of Natural Capsules shares is Rs 10, while the book value per share of Natural Capsules is around Rs 171.4734. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Natural Capsules?
Ans: Natural Capsules has a total debt of Rs 58.1232 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Natural Capsules?
Ans: The ROE of Natural Capsules is 6.5119% and ROCE of Natural Capsules is 9.2754%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Natural Capsules a good buy for the long term?
Ans: The Natural Capsules long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Natural Capsules undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Natural Capsules appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Natural Capsules’s financials?
Ans: You can review Natural Capsules’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Natural Capsules
X